[
  {
    "variant_id": {
      "Gene": "parkin",
      "Protein_Change": {
        "ref": "Unknown",
        "alt": "Mutant parkins from AR–JP patients",
        "position": "N/A"
      },
      "variant_string_id": "parkin Mutant"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper explains that parkin is involved in protein degradation as a ubiquitin-protein ligase collaborating with UbcH7, and that mutant parkins from AR–JP patients show loss of the ubiquitin-protein ligase activity.",
        "judgment": "Yes",
        "judgment_basis": "The paper clearly defines the mechanism related to the loss of function of parkin in protein degradation."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses functional enzyme activity assays to assess the function of parkin.",
        "judgment": "Yes",
        "judgment_basis": "Functional enzyme activity assays are widely used in the field and are accepted as a means to evaluate enzyme function."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "sub_steps": [
          {
            "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
            "extracted_paper_info": "The paper does not explicitly state whether both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls were used.",
            "judgment": "Partial"
          },
          {
            "sub_step_name": "Sub-step 3b: Accepted/Validated Assay",
            "extracted_paper_info": "Functional enzyme activity assays are widely accepted historically and are a standard technique in the field.",
            "judgment": "Yes"
          },
          {
            "sub_step_name": "Sub-step 3c: Variant Controls",
            "extracted_paper_info": "The paper does not explicitly state whether known pathogenic variants, known benign variants, or variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves were used.",
            "judgment": "Partial"
          }
        ]
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "sub_steps": [
          {
            "sub_step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The paper does not perform statistical analyses on the functional data for this variant.",
            "judgment": "No"
          },
          {
            "sub_step_name": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
            "extracted_paper_info": "The paper does not report the total number of benign/pathogenic variant controls used across the entire study.",
            "judgment": "N/A"
          }
        ]
      }
    ],
    "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting",
    "rationale": "While the study does not explicitly use known pathogenic and benign variants as controls, it uses a functional enzyme activity assay which is widely accepted in the field. However, since basic controls and variant controls were only partially addressed, the functional evidence strength can be considered maximally supporting for a pathogenic interpretation."
  }
]